Trial Profile
Ipilimumab in Asian patients with advanced melanoma
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Expanded access; Therapeutic Use
- 17 Jul 2015 New trial record
- 02 Jun 2015 Preliminary results in 31 patients presented at the 51st Annual Meeting of the American Society of Clinical Oncology.